None listed
Conditions
Brief summary
Observations from previous studies suggest that testosterone acts on liver to induce protein anabolic effect. We will test the hypothesis that testosterone by acting on the liver, preserves protein loss in healthy men.
Interventions
Oral micronised testosterone 40 mg daily for 14 days.
Adherence to treatment will be monitored by drug return.
Sponsors
Garvan Institute
Study design
Allocation
Non-randomised trial
Intervention model
Single group
Primary purpose
Treatment
Masking
Open (masking not used)
Eligibility
Sex/Gender
Male
Age
60 Years to 75 Years
Healthy volunteers
Yes
Inclusion criteria
Healthy men
Exclusion criteria
Endocrine disorders
Outcome results
None listed